Hexagon Nutrition credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
30.3
−25.0
0.13×
−0.11×
0.58×
−0.48×
10.68×
11.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HEXAGON₹57.32

Hexagon Nutrition Limited

· Pharma & Health
₹ CroreMcap ₹634 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Total Debt30.3
Net Debt-25.0
Total Debt/Equity0.13
Net Debt/Equity-0.11
Total Debt/EBITDA0.58
Net Debt/EBITDA-0.48
Interest Coverage (EBIT/Interest)10.68
Total Debt/Total Capital %11.50
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.